Browse > Article

Central and Peripheral Distribution of Bone Marrow on Bone Marrow Scintigraphy with Antigranulocytic Antibody in Hematologic Malignancy  

Kang, Do-Young (Department of Nuclear Medicine, Dong-A University College of Medicine)
Lee, Jae-Tae (Department of Nuclear Medicines, Kyungpook University School of Medicine)
Sohn, Sang-Kyun (Department of Nuclear Medicines, Kyungpook University School of Medicine)
Lee, Kyu-Bo (Department of Nuclear Medicines, Kyungpook University School of Medicine)
Publication Information
The Korean Journal of Nuclear Medicine / v.36, no.5, 2002 , pp. 298-305 More about this Journal
Abstract
Purpose: Bone marrow scintigraphy has been used to evaluate the status of bone marrow in various hematologic disorders. We have analyzed the peripheral distribution pattern and central uptake ratio of bone marrow using anti-NCA-95 monoclonal antibody and the their correlation in patients with various hematologic malignancy. Materials and Methods: Bone marrow immunoscintigraphy was performed using Tc-99m anti-granulocyte monoclonal mouse antibody BW 250/183. Fifty patients were classified into four groups; 11 with acute myelogenous leukemia, 12 with acute lymphocytic leukemia, 15 with lymphoma and 12 with myelodysplastic syndrome. The extension of peripheral bone marrow was categorized into four grades: I, II, III and IV. The activity of central bene marrow was expressed as sacroiliac uptake ratio. Results: The patient's number was 4 in grade I, 27 in grade II, 15 in grade III and 4 in grade IV according to extension of peripheral bone marrow. The extension of peripheral bone marrow was marked (58% in grade III and IV) in myelodysplastic syndrome and acute lymphocytic leukemia and mild (93% in grade I and II) in lymphoma. Sacroiliac uptake ratio was highest ($8.5{\pm}4.0$) in myelodysplastic syndrome and lowest ($5.9{\pm}3.6$) in acute myelogenous leukemia, but not significantly different among four patient groups (p>0.05). Sacroiliac uptake ratio of whole patients was significantly different among four grades (p=0.003), but there was not correlated between grade of peripheral bone marrow and sacroiliac uptake ratio (r=0.05). Conclusion: The pattern of peripheral bone marrow extension and activity of central hemopoietic marrow were not specific to the disease entities. Response of hemopoietic bone marrow may be evaluated on both peripheral and central bone marrow in patients with hematologic malignancy.
Keywords
Bone marrow scintigraphy; Hematologic malignancy; Tc-99m antiNCA-95;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Jakubowski A, Scheinberg DA. Noninvasiveevaluation of the bone marrow (editorial). J NuclMed 1996;37:982-4.
2 Sayle BA, Helmer RE, Birdsong BA, BalachandranS, Gardner PH. Bone-marrow imaging with indium-Ill chloride in aplastic anemia and myelofibrosis: concise communication. J Nucl Med 1982;23: 121-5.
3 Lee KH, Chung JK, Choi CH, Jeong JM, LeeDS, Bang YJ, et al. Technetium-99m-labeledantigranulocyte antibody bone marrow scintigraphy.J Nucl Med 1995;36:1800-5.
4 Kim DH, Lee J, Baek JH, Jung JT, Hyun DW,Chun KA, et al. Bone marrow scintigraphy withanti granulocyte antibody in multiple myeloma:comparison with simple radiography and bonescintigraphy. Korean J Nucl Med 1998;32:354-64.
5 Reske SN. Recent advances in bone marrowscanning. Eur J Nucl Med 1991;18:203-21.
6 Hoppin EC, Lewis JP, Denardo SJ. Bonemarrow scintigraphy in the evaluation of acutenonlymphocytic leukemia. Clin Nucl Med 1979;7:296-301.
7 Huic D, Ivancevic V, Richter WS, Munz DL.Immunoscintigraphy of the bone marrow: normaluptake values of technetium-99m-Iabeled monoclonalantigranulocyte antibodies. J Nucl Med1997;38: 1755-8.
8 Kuroki M, Koga Y, Matsuoka Y. Monoclonalantibodies to carcinoembryonic antigen: a systemicanalysis of antibody specificities by usingrelated normal antigrdens and evidence for allotypicdeterminants on carcinoembryonic antigen.J Immunol 1984;133:2090-7.
9 Buchegger F, Schreyer M, Carral S. Monoclonalantibodies identify a CEA cross-reacting antigenof 95 kDa (NCA-95) distinct in antigenicity andtissue distribution from the previously describedNCA of 55 kDa. Int J Cancer 1984;33:839-45.
10 Chung JK, Yeo J, Lee DS, Park S, Lee MC,Kim BK, et al. Bone marrow scintigraphy usingtechnetium-99m antigranulocyte antibody inhematologic disorders. J Nucl Med 1996;37:978-82.
11 Cho JH, Kim MJ, Lee JD, Park CY, Kim KY.Evaluation of bone marrow involvement inleukemic patients using bone marrow scan.Korean J Nucl Med 1993;27:298-304.
12 Byfield JE, Klisak I, Bennett LR. Thermalmarrow expansion: effect of temperature onbone marrow distribution. Int J Radiation OncologyBioi Phys 1984;10:875-83.
13 Duncker CM, Carrio I, Bema L, Estorch M,Alonso C, Oheda B, et al. Radioimmuneimaging of bone marrow in patients withsuspected bone metastases from primary breastcancer. J Nucl Med 1990;31:1450-5.
14 Lee YH, Lee J, Paik JH, Kim DH, Chung JT,Chun KA, et al. Scintigraphic evaluation ofhematologic diseases with Tc-99m labeledantigranulocyte antibody. Korean J Hematol1998;33:206-14.
15 Moore SG, Dawson KL. Red and yellowmarrow in the femur: age-related changes inappearance at MR imaging. Radiology 1990;175:219-23.
16 Agren B, Rudberg U, Mare K, Aspelin P. Bonemarrow imaging of bone marrow transplantedmultiple myeloma patients. Clin Nucl Med1997;22:80-92.
17 Najean Y, Danvic ML, Mercier NL, Pecking A,Colonna P, Rain JD. Significance of bonemarrowscintigraphy in aplastic anemia: concisecommunication. J Nucl Med 1980;21:213-8.
18 Munz DL. Bone marrow scanning. principles,clinical results and indications. Radiologe 1992;32:485-94.